Patents
Sitemap › G01 - Measuring; Testing › G01N - Investigating or analysing materials by determining their chemical or physical properties › G01N 33 - Investigating or analysing materials by specific methods not covered by groups
Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632)
10/2007
10/26/2007CA2586188A1 Apparatus and method to administer and manage an intelligent base unit for a handheld medical device
10/26/2007CA2541872A1 H5 pseudotyped viruses and uses thereof
10/25/2007WO2007121465A2 Detection of proteins from circulating neoplastic cells
10/25/2007WO2007121464A2 Detection of circulating endothelial cells
10/25/2007WO2007121459A2 Detection of steroid receptors on circulating carcinoma cells and treatment
10/25/2007WO2007121186A2 Crac modulators and use of same for drug discovery
10/25/2007WO2007121184A2 Compounds and methods for diagnosis and treatment of leishmaniasis
10/25/2007WO2007121121A2 Laminated biosensor and its manufacturing method
10/25/2007WO2007120947A1 Molecules for the treatment of lung disease involving an immune reaction to connective tissue found in the lung
10/25/2007WO2007120806A2 Method of measuring residual cancer and predicting patient survival
10/25/2007WO2007120762A2 Fluorescent particles bound to multifunctional scaffolds and their uses
10/25/2007WO2007120699A2 Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds & other chemicals
10/25/2007WO2007120658A1 Melanoma biomarker and methods of uses
10/25/2007WO2007120553A2 System and method for estimating filtrate contamination in formation fluid samples using refractive index
10/25/2007WO2007120522A2 Permuted and nonpermuted luciferase biosensors
10/25/2007WO2007120478A2 Glycomic patterns for the detection of disease
10/25/2007WO2007120311A2 Detection of soluble adiponectin receptor peptides and use in diagnostics and therapeutics
10/25/2007WO2007120252A2 Soluble human m-csf receptor and uses thereof
10/25/2007WO2007120214A1 Hand-held gas detector and method of gas detection
10/25/2007WO2007120170A2 Compositions and methods for treating gram positive bacterial infection in a mammalian subject
10/25/2007WO2007120154A2 Methods of oligosaccharide profiling for the detection of ocular rosacea
10/25/2007WO2007120095A1 Detection device and method
10/25/2007WO2007120044A1 Capacitive sensor, method for manufacturing such a sensor and mould provided with such a sensor.
10/25/2007WO2007120034A1 Method for rapid detection of lymphatic filariasis
10/25/2007WO2007119991A1 Bio-chip of pattern-arranged in line, method for manufacturing the same, and method for detecting an analyte bound in the same
10/25/2007WO2007119987A2 Kit and method for quantitatively detecting multiplepathogens without gene amplification
10/25/2007WO2007119928A1 The ultra filtration system for on-line analyzer
10/25/2007WO2007119787A1 Phosphatase involved in the regulation of cardiomyocyte differentiation
10/25/2007WO2007119759A1 Dopamine-producing neuron progenitor cell marker 187a5
10/25/2007WO2007119685A1 METHOD FOR TESTING ALZHEIMER'S DISEASE BY ASSAYING DEGRADATION RATE OF β-AMYLOID IN BLOOD AND DIAGNOSTIC REAGENT
10/25/2007WO2007119623A1 Novel use of g-protein-conjugated receptor and ligand thereof
10/25/2007WO2007119606A1 Method for determination of prognosis of prostate cancer, and diagnostic agent for use in the method
10/25/2007WO2007119563A1 Human megalin determination method
10/25/2007WO2007119515A1 Novel tumor antigen peptides
10/25/2007WO2007119481A1 Diagnosis of acute enteritis by determination of intestinal fatty acid-binding protein in the blood
10/25/2007WO2007119431A1 Non-heating detection method for dermatophyte
10/25/2007WO2007119237A1 Methods and kits for diagnosing oxidative stress associated diseases
10/25/2007WO2007119229A1 Sensor comprising conducting polymer materials
10/25/2007WO2007119191A1 Foam inhibitor membrane for a flow-through cell
10/25/2007WO2007119165A2 A method for detecting intracytoplasmic protein/protein interactions
10/25/2007WO2007119111A2 Tissue diagnostics for ovarian cancer
10/25/2007WO2007119101A2 Assay system for glp-2 receptor ligands
10/25/2007WO2007119044A1 Apparatus and method for detecting arsine and phosphine comprising a chemical conversion cell
10/25/2007WO2007119004A2 Method for diagnosing in vitro or ex vivo psychiatric disorders and/or intestinal dysbioses
10/25/2007WO2007118983A1 C4d/c4b standard for quantitative flow cytometry of humoral transplant rejection
10/25/2007WO2007118712A1 Method and reagent for the specific identification and quantification of one or more proteins in a sample using inductively coupled plasma-mass spectrometry
10/25/2007WO2007118598A2 Spinning device for producing a yarn
10/25/2007WO2007118329A1 Methods and agents for treating tuberculosis
10/25/2007WO2007098102A3 Free ngal as a biomarker for cancer
10/25/2007WO2007097625A3 Process and device for preparing pre-fried or deep-fried starch containing food products
10/25/2007WO2007096142A3 Vascular tumor markers
10/25/2007WO2007092892A3 Geomorphology for environmental remediation processes and systems including sediment survey
10/25/2007WO2007089903A3 Cationic steroid microbial compositions for treating or preventing influenza infections
10/25/2007WO2007088537A3 Methods and kits for early detection of cancer or predisposition thereto
10/25/2007WO2007081385A3 Microfluidic devices and methods of use in the formation and control of nanoreactors
10/25/2007WO2007081203A3 System for measuring filter saturation
10/25/2007WO2007080621A8 Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof
10/25/2007WO2007079386A3 Method of diagnosing a body weight condition or predisposition in an animal
10/25/2007WO2007063300A3 Particles
10/25/2007WO2007062063A3 Recombinant viral compositions and uses thereof
10/25/2007WO2007055916A3 Reagents, methods and systems for selecting a cytotoxic antibody or variant thereof
10/25/2007WO2007054799B1 Real-time calibration for downhole spectrometer
10/25/2007WO2007053731A3 Expression of soluble factor viii proteins in bacteria
10/25/2007WO2007051069A3 Urinary proteomic biomarker patterns in preeclampsia
10/25/2007WO2007041502A3 Methods for determining responsiveness to cancer therapy
10/25/2007WO2007040566A3 Method and apparatus for interfacial sensing
10/25/2007WO2007033078A3 Magnetic particle-tagged blood bank reagents and techniques
10/25/2007WO2007030830A3 Methods and organisms for the growth-coupled production of succinate
10/25/2007WO2007021819A3 Biochemical assay methods
10/25/2007WO2007011936A2 Lateral flow assay and device using magnetic particles
10/25/2007WO2007002641A3 Method for identifying cart receptor and uses thereof
10/25/2007WO2006133145A3 Tat-007 and methods of assessing and treating cancer
10/25/2007WO2006117225B1 Competitive n-hybrid system
10/25/2007WO2006047759A3 Kinase inhibitors for the treatment of diabetes and obesity
10/25/2007WO2006044855A3 Method and system for determining an optimal amount of a pharmaceutical to be administered to a patient during surgery
10/25/2007WO2005103687A3 System and method for providing optimal concentrations for medication infusions
10/25/2007WO2004086953A3 Method for diagnosis and treatment of bone turnover
10/25/2007WO2002099074A3 Slc7s as modifiers of the p53 pathway and methods of use
10/25/2007US20070250940 Transgenic mice for bioassay of prions from deer and elk with chronic wasting disease
10/25/2007US20070250271 Method of compensation of dose-response curve of an essay for sensitivity to perturbing variables
10/25/2007US20070250270 Cellular predictive models for toxicities
10/25/2007US20070249813 recombinant human antibodies containing CDR3 domain having an amino acid sequence with alanine substitutions that specifically bind to human tumor necrosis factor alpha (hTNF alpha ) to treat autoimmune disorders ( rheumatic arthritis, allergy, multiple sclerosis, autoimmune diabetes)
10/25/2007US20070249734 Method, Composition and Kit for Detecting Phosphatidylserine (Ps) on Cell Membranes
10/25/2007US20070249641 Adenosine a3 receptor modulators
10/25/2007US20070249628 Use of Mast Cells Inhibitors for Treating Patients Exposed to Chemical or Biological Weapons
10/25/2007US20070249605 such as methyl 2-(4-hydroxy-1-methyl-2-oxo-1,2-dihydroquinoline-3-carboxamido)acetate
10/25/2007US20070249555 Use of Atp Analogues for Treatment of Cardiovascular Diseases
10/25/2007US20070249531 Method for the Detection of Autoantibodies Against Specific Peptides and Its Use in Diagnosis and Treatment of Pregnancy-Loss or Infertility
10/25/2007US20070249530 Bcma Polypeptides and Uses Thereof
10/25/2007US20070249064 Quantum dots and their uses
10/25/2007US20070249063 Biosensors
10/25/2007US20070249062 Microfluidic Chip
10/25/2007US20070249061 Screening method of new drug candidates using protein interaction happening after binding a small amount of protein on high sensitive protein chip; can be used for research of protein-protein interactions; peptide composition for treating cancer
10/25/2007US20070249060 Determination of Proteins and/or Other Molecules Using Mass Spectroscopy
10/25/2007US20070249059 Phase change sensor
10/25/2007US20070249058 Hydrocarbon dewpoint measurement device and method
10/25/2007US20070249057 used in the testing of personal care absorbent products; for in vitro testing of feminine hygiene products
10/25/2007US20070249056 Peptide and Protein Fragmentation by Lysine Residue Originated Reactions
10/25/2007US20070249055 Method of measuring lotion and additive ingredient transfer
10/25/2007US20070249037 Monitoring of Vitamin K Nutritional Status
1 ... 1573 1574 1575 1576 1577 1578 1579 1580 1581 1582 1583 1584 1585 1586 1587 1588 1589 1590 1591 1592 1593 ... 3937